Bernhard shared great insights and advice from his 8 years of leading the Evonik fund, which is a GP / LP separate legal structure. We had great insights to the portfolio of 30 venture investments, being on the boards, current cash and business challenges. The discussion with the group was especially good on the current valuations and terms for follow on, before then discussing the challenges and opportunities for new investments as there is a lot of disruptive change occurring. The session was May 2020
Future sessions at https://www.eventbrite.co.uk/o/andrew...

Key contributors to this session
Bernhard Mohr Managing Director, Evonik Ventures
Andrew Gaule, CEO of Aimava